Sign in
4

Changes in Ownership

Zentalis Pharmaceuticals, Inc. Filed Acc 0001838041-26-000002

Options or other derivatives

  • Chief Medical Officer acquired 365,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bruns Ingmar · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +365,000 365,000 D
Loading xslF345X05/wk-form4_1768008888.xml…